[Expensive new drugs requires reflection and revision: Narrow interpretation of ethical platform]

Lakartidningen. 2015 Jun 1:112:DH94.
[Article in Swedish]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis / ethics*
  • Drug Costs / ethics*
  • Humans